Deliver Your News to the World

CybeRelease: (OTC: CCRC) Clinicares Expands Into the China Market


(CybeRelease, May 22, 2007) - Lake Harmony, PA - Clinicares (OTC PK: CCRC) announced the signing of a contract with the People’s Liberation Army Hospital in Beijing, China to provide their functional beauty products, customized beauty products and their DNA Gene testing/diagnosis services. Clinicares will also have the license to provide its products and services to dermatologists and plastic surgeons within the Hospital. The doctors and medical personnel are especially interested in the micro needles because of the number of Chinese patients with scars.

Due to the size of the Chinese market and the anticipated demand for their products and services, Clinicares forecasts a significant increase in sales once established in China.

Clinicares will start the interior construction of their examining center facility in the Beijing Hospital by the end of the month and expects operations to begin within six months.

About Clinicares

Micro Roller and Peptide Product line:

With the conventional application of creams, gels or lotions only a fraction (less than 0.5%) of their active substances can penetrate the epidermal barrier (99.5% is lost). The upper skin layer (epidermis) consists of several layers and their structure is like a brick-wall.

The Clinicares Micro Roller, studded with nearly 200 extreme fine needles of medical grade stainless steel with a tip length of 0.2mm, is the latest revolutionary cosmeceutical tool in skin care treatments. When applied to the surface of the skin, it creates deep micro channels in the layer of dead cells that normally protects the skin. These enable the active ingredients of peptide-based products to penetrate more deeply and in greater quantities than simply applying the preparation to the surface.

To read the complete release, go to

For a Free Newsletter, go to

CybeRelease Gainers are Citrix Systems, Inc. (Nasdaq: CTXS), CORUS Bankshares, Inc. (Nasdaq: CORS), FSI International, Inc. (Nasdaq: FSII), Energy Conversion Devices, Inc. (Nasdaq: ENER), Children’s Place Retail Stores, Inc. (The) (Nasdaq: PLCE), SunPower Corporation (Nasdaq: SPWR), NutriSystem Inc. (Nasdaq: NTRI) and Penn National Gaming, Inc. (Nasdaq: PENN).

CybeRelease Decliners are SanDisk Corporation (Nasdaq: SNDK), Monster Worldwide, Inc. (Nasdaq: MNST), LifePoint Hospitals, Inc. (Nasdaq: LPNT), GigaMedia Limited (Nasdaq: GIGM), United Natural Foods, Inc. (Nasdaq: UNFI), Sepracor Inc. (Nasdaq: SEPR), Tech Data Corporation (Nasdaq: TECD) and Focus Media Holding Limited (Nasdaq: FMCN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.